Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Gut-Brain Axis01:22

Gut-Brain Axis

39
The gut–brain axis is a bidirectional communication system that connects the gastrointestinal tract and the brain. This interaction is mediated through multiple pathways, including the vagus nerve, hormonal signals, immune responses, and chemical messengers produced by gut microbes.Microbial Contributions to Brain FunctionGut microbiota contributes significantly to brain function by producing neuroactive compounds. These include neuroactive compounds that influence neurotransmitters such...
39

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Temporal Trends and Cross-Country Inequalities in the Burden of Osteoarthritis, 1990-2021: Findings From the Global Burden of Disease Study 2021.

International journal of rheumatic diseases·2026
Same author

Plasma proteomic signatures of early retinal neurodegeneration in diabetes: A multi-cohort study.

PLoS medicine·2026
Same author

Assessing overall PrEP uptake, daily PrEP and event-driven PrEP use among men who have sex with men in 15 countries across Asia.

Sexual health·2026
Same author

Moderating Role of Condom-Use Inertia on the Association Between Status Quo Bias and Pre-Exposure Prophylaxis Resistance Intention Among Chinese Men Who Have Sex With Men: Cross-Sectional Study.

JMIR public health and surveillance·2026
Same author

Global Trends and Inequalities in Diabetes Prevalence and Treatment Coverage Among Adults Aged ≥ 45 Years, 1990-2040: Insights From the NCD-RisC Database.

Diabetes/metabolism research and reviews·2026
Same author

Neurovascular retinomics for predicting heart diseases.

Cardiovascular research·2026

Related Experiment Video

Updated: Mar 27, 2026

Author Spotlight: Exploring Sex-Specific Glial Signatures and Therapeutic Leads for Alzheimer's Disease
04:22

Author Spotlight: Exploring Sex-Specific Glial Signatures and Therapeutic Leads for Alzheimer's Disease

Published on: May 20, 2024

1.5K

Identifying candidate gut microbiota indicators for Alzheimer's disease through integrated data.

Jing Wang1,2, Hanting Liu3, Hao Lai2

  • 1Phase I clinical trial research ward, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, China.

Msystems
|March 25, 2026
PubMed
Summary

Researchers identified key gut bacteria linked to Alzheimer's disease (AD) and mild cognitive impairment (MCI). Specific bacterial genera show diagnostic potential for AD, offering new avenues for non-invasive biomarkers and therapies.

Keywords:
Alzheimer's diseasecandidate indicatordiscriminative modelgut microbiotarandom forest

More Related Videos

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches
09:47

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches

Published on: December 15, 2023

2.0K
Microbiota Analysis Using Two-step PCR and Next-generation 16S rRNA Gene Sequencing
11:22

Microbiota Analysis Using Two-step PCR and Next-generation 16S rRNA Gene Sequencing

Published on: October 15, 2019

31.5K

Related Experiment Videos

Last Updated: Mar 27, 2026

Author Spotlight: Exploring Sex-Specific Glial Signatures and Therapeutic Leads for Alzheimer's Disease
04:22

Author Spotlight: Exploring Sex-Specific Glial Signatures and Therapeutic Leads for Alzheimer's Disease

Published on: May 20, 2024

1.5K
Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches
09:47

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches

Published on: December 15, 2023

2.0K
Microbiota Analysis Using Two-step PCR and Next-generation 16S rRNA Gene Sequencing
11:22

Microbiota Analysis Using Two-step PCR and Next-generation 16S rRNA Gene Sequencing

Published on: October 15, 2019

31.5K

Area of Science:

  • Microbiome research
  • Neurodegenerative disease biomarkers
  • Computational biology and bioinformatics

Background:

  • Alzheimer's disease (AD) is increasingly linked to gut microbiota dysbiosis.
  • Identifying reliable gut microbiota biomarkers is crucial for early AD diagnosis.
  • Previous studies often lack large-scale, multi-population data for robust biomarker discovery.

Purpose of the Study:

  • To characterize gut microbiota composition and diversity in AD patients across diverse populations.
  • To identify reliable gut microbiota indicators with diagnostic value for AD.
  • To explore the potential of these indicators for non-invasive AD diagnosis and targeted therapies.

Main Methods:

  • Integrated public data from AD dementia, mild cognitive impairment (MCI), and normal control (NC) groups.
  • Conducted microbiota composition, diversity (α-diversity), and network analyses.
  • Utilized seven common statistical methods to identify differential bacterial genera as candidate indicators.

Main Results:

  • The AD dementia group exhibited significantly lower α-diversity and reduced microbial network density compared to MCI and NC groups.
  • Identified 35 bacterial genera as candidate AD indicators, including novel findings for *RF39* and *Oligella*.
  • *Faecalibacterium* emerged as the top indicator overall, with population-specific key indicators like *Akkermansia* (Chinese) and *Collinsella* (Turkish/Kazakh).

Conclusions:

  • Gut microbiota alterations, including reduced diversity and network complexity, are characteristic of AD dementia.
  • A panel of 35 bacterial genera shows promise as diagnostic biomarkers for AD.
  • Findings support the development of non-invasive AD diagnostic tools and microbiota-targeted therapeutic strategies.